W. Riese

发表

Single-Center Experience With the Dual-Focus Storz Modulith SLX-F2 Lithotripter: A Retrospective Study

T. Nelius, S. Filleur, J. Chandrapal, 2014 .

Re: Impact of 2012 USPSTF Screening PSA Guideline Statement: Changes in Primary Care Provider Practice Patterns and Attitudes

W. Riese, K. Verlage, R. Grand, 2017 .

Intrascrotal metastases from renal cell carcinoma

B. Aeikens, W. Riese, H. Warmbold, 2005, International Urology and Nephrology.

Intrascrotal metastases of renal cell carcinoma: Two case reports and a review of the literature

B. Aeikens, E. Schindler, W. Riese, 1986, World Journal of Urology.

Proliferation Kinetics and Prognosis of Renal Cell Carcinoma

C. Stief, H. Kirchner, J. Atzpodien, 1991 .

Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors

T. Ulbright, T. Senge, J. Messemer, 2004, Urological Research.

Risk F actors f or R elapse i n C linical S tage I N onseminomatous Testicular G erm C ell T umors: R esults o f t he G erman Testicular C ancer S tudy G roup T rial

R. Fimmers, P. Albers, L. Weissbach, 2003 .

Adult Dominant Polycystic Kidney Disease (ADPKD) of Medical & Surgical Pathology

W. Riese, 2016 .

Immunotherapy of advanced renal cell cancer using subcutaneous recombinant interleukin-2 and interferon-α

H. Kirchner, H. Poliwoda, J. Atzpodien, 1991, World Journal of Urology.

Outpatient Therapy of Advanced Malignancies Using Recombinant Interleukin-2 and Recombinant Interferon-α With or Without Chemotherapy

H. Kirchner, H. Poliwoda, T. Menzel, 1992 .

Clinical outcome of patients with docetaxel-resistant hormone-refractory prostate cancer treated with second-line cyclophosphamide-based metronomic chemotherapy

T. Klatte, T. Nelius, S. Filleur, 2010, Medical oncology.

Comparison of Human Normal Renal Cells and Malignant Renal Cells In Vivo and In Vitro Using Cytological, Cytochemical, and Immunocytochemical Methods

U. Jonas, U. Pohl, S. Warnaar, 1989 .

Short-Term In-Vitro Sensitivity Testing of Human Renal Cell Carcinoma

S. Szücs, G. Kovacs, E. Schindler, 1987 .

Prostate-specific antigen—comparative clinical appreciation of a serodiagnostic measure after 8 years of experience

U. Jonas, E. Allhoff, W. Riese, 1989, World Journal of Urology.

Single potential analysis of cavernous electrical activity

C. Stief, U. Jonas, W. Thon, 2004, Urological Research.

Growth-Modulating Effects of Interleukin-lα, Interleukin-1β, and Macrophage Colony-Stimulating Factor in Clonogenic Tumor Cells In Vitro

M. Freund, H. Meyer, A. Hanauske, 1992 .

Effects of cytokines on growth in vitro of primary human renal cell carcinoma

C. Stief, H. Kirchner, J. Atzpodien, 2004, Urological Research.

The Clinical Association of Autosomal Dominant Polycystic Kidney Disease and renal cell Carcinoma

W. Riese, R. Tran, W. Lane, 2011 .

Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy

T. Klatte, T. Nelius, S. Filleur, 2007, International Urology and Nephrology.

Stage I Seminoma of the Testis

C. Stief, B. Schneider, E. Allhoff, 1991 .

Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administered with soluble GM-CSF

Laura A. Sullivan, R. K. Bright, J. Byrne, 2009, Cancer Immunology, Immunotherapy.

Effects of Interleukin-6 on Soft Agar Colony Formation of Primary Solid Tumor Specimens

K. Welte, S. Sandner, M. Freund, 1992 .

Proliferative behaviour and cytogenetic changes in human renal-cell carcinoma

C. Stief, U. Jonas, H. Kirchner, 1991, World Journal of Urology.

In vitro sensitivity testing of human renal cell carcinoma with cytostatic agents and interferon alpha-2a

C. Stief, U. Jonas, E. Allhoff, 2004, Urological Research.

Investigation of the Tumor Capsule in Renal Cell Carcinoma and Its Significance for Treatment

C. Stief, H. Kirchner, E. Reale, 1994 .

PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ.

R. Kennedy, T. Nelius, S. Filleur, 2011, Cytokine.

Current clinical relevance of immunotherapy in metastatic renal cell cancer

C. Stief, U. Jonas, H. Kirchner, 1991, World Journal of Urology.

RRU_A_231954 351..357

W. Riese, C. Riese, 2019 .

The Association between Autosomal Dominant Polycystic Kidney Disease and Renal Cell Carcinoma

W. Riese, C. Hansen, J. Cammack, 2015 .

Adult Dominant Polycystic Kidney Disease (ADPKD)

W. Riese, 2017 .

Review of New Implantable Tibial Nerve Stimulators in Comparison to Established Third Line Treatment Modalities for Nonneurogenic Overactive Bladder.

W. D. de Riese, C. D. de Riese, W. Riese, 2020, Urology practice.

Complete spontaneous regression in metastatic renal cell carcinoma — an update and review

C. Stief, U. Jonas, H. Kirchner, 1991, World Journal of Urology.

Effects of Interleukin-4, Interleukin-5, and Interleukin-7 on Clonogenic Growth of Primary Human Tumors In Vitro

M. Freund, M. Oelke, H. Meyer, 1992 .

Metastatic renal cell carcinoma (RCC): Spontaneous regression, long-term survival and late recurrence

C. Stief, U. Jonas, E. Allhoff, 2006, International Urology and Nephrology.

Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review

Shengping Yang, Phillip Watkins, A. Haynes, 2015, International Urology and Nephrology.

Implications on clinical management of the small renal mass in patients 80 years of age and older based on a retrospective review of the SEER database

M. Wachtel, A. Haynes, W. Riese, 2015, International Urology and Nephrology.

Adenocarcinoma in extrophy of the bladder

W. Riese, H. Warmbold, 1986, International Urology and Nephrology.

Clinical outcome of patients (pts) with taxane-resistant (TR) hormone-refractory prostate cancer (HRPC) treated with second-line cyclophosphamide (CP) -based metronomic chemotherapy

T. Klatte, T. Nelius, W. Riese, 2007 .

434 TWO FUNCTIONAL EPITOPES OF PEDF BLOCK ANGIOGENESIS AND INDUCE DIFFERENTIATION IN PROSTATE CANCER

O. Volpert, T. Nelius, W. Riese, 2007 .

Experimental Approach for Assessment of Tumor Biology in Clinical Stage I Nonseminomatous Germ Cell Tumors (NSGCT)

C. Stief, C. Wittekind, H. Schmoll, 1991 .